Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nuria Espinosa

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Plos One|April 8, 2021
Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIVRamón Teira, Helena Diaz-Cuervo, Filipa Aragão, et al.
Open Respiratory Archives|April 15, 2024
Repeated Pulses of Methyl-Prednisolone in Adults Hospitalized With COVID-19 Pneumonia and Acute Respiratory Distress Syndrome: A Preliminary Before-After Study (CortiCOVID Study)Michelle Espinosa-Solano, Demetrio Gonzalez-Vergara, Marta Ferrer-Galvan, et al.
Cellular & Molecular Immunology|July 22, 2021
Dendritic cell deficiencies persist seven months after SARS-CoV-2 infectionAlberto Pérez-Gómez, Joana Vitallé, Carmen Gasca-Capote, et al.
Antibiotics (Basel, Switzerland)|November 20, 2020
Impact of the COVID-19 Pandemic on Antimicrobial Consumption and Hospital-Acquired Candidemia and Multidrug-Resistant Bloodstream InfectionsAna Belen Guisado-Gil, Carmen Infante-Domínguez, Germán Peñalva, et al.
Journal of Medical Virology|December 12, 2023
Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019-2021Laura Viñuela, Adolfo de Salazar, Ana Fuentes, et al.
The Journal of Antimicrobial Chemotherapy|March 7, 2019
Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practiceMarta Alvarez, Paz Casas, Adolfo de Salazar, et al.
JCI Insight|July 9, 2024
Vedolizumab and ART in recent HIV-1 infection unveil the role of α4β7 in reservoir sizeMaria Reyes Jimenez-Leon, Carmen Gasca-Capote, Cristina Roca-Oporto, et al.
HIV Medicine|May 18, 2026
Hodgkin and non-Hodgkin lymphomas in the post-antiretroviral therapy era according to HIV virological suppressionTeresa Aldámiz-Echevarria, Francisco Tejerina, Chiara Fanciulli, et al.
Open Forum Infectious Diseases|June 10, 2026
Beyond Surveillance Mutations: Long-Term Trends and Clinical Relevance of Transmitted HIV Drug Resistance in Spain (2007-2023)Paloma Muñoz Báez, Marta Illescas López, Adolfo de Salazar, et al.
Plos One|November 13, 2019
Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r ± dasabuvir ± ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human immunodeficiency virus-1 in SpainJosé Manuel Sousa, Mercedes Vergara, Federico Pulido, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Plos One|April 8, 2021
Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIVRamón Teira, Helena Diaz-Cuervo, Filipa Aragão, et al.
Open Respiratory Archives|April 15, 2024
Repeated Pulses of Methyl-Prednisolone in Adults Hospitalized With COVID-19 Pneumonia and Acute Respiratory Distress Syndrome: A Preliminary Before-After Study (CortiCOVID Study)Michelle Espinosa-Solano, Demetrio Gonzalez-Vergara, Marta Ferrer-Galvan, et al.
Cellular & Molecular Immunology|July 22, 2021
Dendritic cell deficiencies persist seven months after SARS-CoV-2 infectionAlberto Pérez-Gómez, Joana Vitallé, Carmen Gasca-Capote, et al.
Antibiotics (Basel, Switzerland)|November 20, 2020
Impact of the COVID-19 Pandemic on Antimicrobial Consumption and Hospital-Acquired Candidemia and Multidrug-Resistant Bloodstream InfectionsAna Belen Guisado-Gil, Carmen Infante-Domínguez, Germán Peñalva, et al.
Journal of Medical Virology|December 12, 2023
Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019-2021Laura Viñuela, Adolfo de Salazar, Ana Fuentes, et al.
The Journal of Antimicrobial Chemotherapy|March 7, 2019
Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practiceMarta Alvarez, Paz Casas, Adolfo de Salazar, et al.
JCI Insight|July 9, 2024
Vedolizumab and ART in recent HIV-1 infection unveil the role of α4β7 in reservoir sizeMaria Reyes Jimenez-Leon, Carmen Gasca-Capote, Cristina Roca-Oporto, et al.
HIV Medicine|May 18, 2026
Hodgkin and non-Hodgkin lymphomas in the post-antiretroviral therapy era according to HIV virological suppressionTeresa Aldámiz-Echevarria, Francisco Tejerina, Chiara Fanciulli, et al.
Open Forum Infectious Diseases|June 10, 2026
Beyond Surveillance Mutations: Long-Term Trends and Clinical Relevance of Transmitted HIV Drug Resistance in Spain (2007-2023)Paloma Muñoz Báez, Marta Illescas López, Adolfo de Salazar, et al.
Plos One|November 13, 2019
Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r ± dasabuvir ± ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human immunodeficiency virus-1 in SpainJosé Manuel Sousa, Mercedes Vergara, Federico Pulido, et al.
Pageof 6